Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study.
Thakur
C P
CP
Kala-azar Research Centre, Patna, Bihar, India.
Kanyok
T P
TP
Pandey
A K
AK
Sinha
G P
GP
Messick
C
C
Olliaro
P
P
D000328:Adult; D000563:Amebicides / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007267:Injections; D007898:Leishmaniasis, Visceral / Q000188:drug therapy*; D008297:Male; D010303:Paromomycin / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome
D000563:Amebicides; D010303:Paromomycin